HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-aminohippuric acid

Also Known As:

o-aminobenzoylglycine; o-aminohippuric acid; ortho-aminohippuric acid

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Avila-Pacheco, Julian: 1 article (05/2021)
2.	Balasubramanian, Raji: 1 article (05/2021)
3.	Clish, Clary B: 1 article (05/2021)
4.	Eliassen, A Heather: 1 article (05/2021)
5.	Frueh, Lisa: 1 article (05/2021)
6.	Jeanfavre, Sarah: 1 article (05/2021)
7.	Tworoger, Shelley S: 1 article (05/2021)
8.	Zeleznik, Oana A: 1 article (05/2021)
9.	Zhao, Yibai: 1 article (05/2021)
10.	Asai, Katsuyuki: 1 article (01/2020)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2020 - "The fraction of patients at each stage of cancer severity were: 41.3% stage I, 8.7% stage II, 19.6% stage III, and 30.4% stage IV. A robust predictive biomarker for lung cancer was selected by the multivariate logistic analysis of fluorescent metabolites and identified to be O-aminohippuric acid (OAH). "
2.	Lung Neoplasms (Lung Cancer) 01/01/2020 - "Urinary fluorescent metabolite O-aminohippuric acid is a useful biomarker for lung cancer detection." 01/01/2020 - "The fraction of patients at each stage of cancer severity were: 41.3% stage I, 8.7% stage II, 19.6% stage III, and 30.4% stage IV. A robust predictive biomarker for lung cancer was selected by the multivariate logistic analysis of fluorescent metabolites and identified to be O-aminohippuric acid (OAH). "
3.	Breast Neoplasms (Breast Cancer) 05/18/2021 - "Seven metabolites remained associated after adjustment for established risk factors (p-value < 0.05) and were selected by at least one multivariable modeling approach: higher levels of 2-aminohippuric acid, kynurenic acid, piperine (all three with q-value < 0.2), DMGV and phenylacetylglutamine were associated with lower breast cancer risk (e.g., piperine: ORadjusted (95%CI) = 0.84 (0.77-0.92)) while higher levels of creatine and C40:7 phosphatidylethanolamine (PE) plasmalogen were associated with increased breast cancer risk (e.g., C40:7 PE plasmalogen: ORadjusted (95%CI) = 1.11 (1.01-1.22)). "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	Plasmalogens
3.	Kynurenic Acid (Kynurenate)
4.	Creatine
5.	phosphatidylethanolamine
6.	piperine
7.	phenylacetylglutamine